NFE2L2 and lobular neoplasia: The antioxidant gene nuclear factor erythroid 2-related factor 2 (NRF2) can significantly inhibit the differentiation of Th17 cells in LN by suppressing ROS, thereby improving prognosis, which also confirms this point (197).